Ausgabe 1/2014
Inhalt (20 Artikel)
Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancers
Julia Y. S. Tsang, Suen-Wah Hui, Yun-Bi Ni, Siu-Ki Chan, Rin Yamaguchi, Ava Kwong, Bonita K. B. Law, Gary M. Tse
CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up
T. Dan, S. M. Hewitt, N. Ohri, D. Ly, B. P. Soule, S. L. Smith, K. Matsuda, C. Council, U. Shankavaram, M. E. Lippman, J. B. Mitchell, K. Camphausen, N. L. Simone
Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties
Namita Kundu, Xinrong Ma, Tyler Kochel, Olga Goloubeva, Paul Staats, Keyata Thompson, Stuart Martin, Jocelyn Reader, Yukinori Take, Peter Collin, Amy Fulton
Adeno-associated virus-mediated expression of recombinant CBD–HepII polypeptide of human fibronectin inhibits metastasis of breast cancer
Zhen-Hui He, Zhang Lei, Yan Zhen, Wei Gong, Bo Huang, Ye Yuan, Gui-Mei Zhang, Xiao-Juan Wang, Zuo-Hua Feng
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
Wojciech M. Ciszewski, Michele Tavecchio, Jarosław Dastych, Nicola J. Curtin
Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing
Milan Radovich, Susan E. Clare, Rutuja Atale, Ivanesa Pardo, Bradley A. Hancock, Jeffrey P. Solzak, Nawal Kassem, Theresa Mathieson, Anna Maria V. Storniolo, Connie Rufenbarger, Heather A. Lillemoe, Rachel J. Blosser, Mi Ran Choi, Candice A. Sauder, Diane Doxey, Jill E. Henry, Eric E. Hilligoss, Onur Sakarya, Fiona C. Hyland, Matthew Hickenbotham, Jin Zhu, Jarret Glasscock, Sunil Badve, Mircea Ivan, Yunlong Liu, George W. Sledge, Bryan P. Schneider
Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers
Toru Hanamura, Toshifumi Niwa, Tatsuyuki Gohno, Masafumi Kurosumi, Hiroyuki Takei, Yuri Yamaguchi, Ken-ichi Ito, Shin-ichi Hayashi
Dual-colour CISH is a reliable alternative to FISH for assessment of topoisomerase 2-alpha amplification in breast carcinomas
Tomás García-Caballero, Olga Prieto, Ángel Vázquez-Boquete, Francisco Gude, Patricia Viaño, María Otero, Teresa Curiel, Beatriz Fernández-Rodríguez, Concepción Parrado, Máximo Fraga, José R. Antúnez
The potential utility of geminin as a predictive biomarker in breast cancer
Sreekumar Sundara Rajan, Andrew M. Hanby, Kieran Horgan, Helene H. Thygesen, Valerie Speirs
Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin
Preeti Shah, Yael Gau, Gauri Sabnis
Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers
Surojeet Sengupta, Michael C. Biarnes, V. Craig Jordan
Comparative efficacy of everolimus plus exemestane versus fulvestrant for hormone-receptor-positive advanced breast cancer following progression/recurrence after endocrine therapy: a network meta-analysis
Thomas Bachelot, Rachael McCool, Steven Duffy, Julie Glanville, Danielle Varley, Kelly Fleetwood, Jie Zhang, Guy Jerusalem
Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery
Michael D. Alvarado, Jay Conolly, Catherine Park, Theadora Sakata, Aron J. Mohan, Brittany L. Harrison, Mitchell Hayes, Laura J. Esserman, Elissa M. Ozanne
Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy
Minhao Fan, Jian Zhang, Zhonghua Wang, Biyun Wang, Qunlin Zhang, Chunlei Zheng, Ting Li, Chen Ni, Zhenhua Wu, Zhimin Shao, Xichun Hu
Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?
Andrew Evans, Petra Rauchhaus, Patsy Whelehan, Kim Thomson, Colin A. Purdie, Lee B. Jordan, Caroline O. Michie, Alastair Thompson, Sarah Vinnicombe
Symptoms of endocrine treatment and outcome in the BIG 1-98 study
J. Huober, B. F. Cole, M. Rabaglio, A. Giobbie-Hurder, J. Wu, B. Ejlertsen, H. Bonnefoi, J. F. Forbes, P. Neven, I. Láng, I. Smith, A. Wardley, K. N. Price, A. Goldhirsch, A. S. Coates, M. Colleoni, R. D. Gelber, B. Thürlimann
CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial
Vincent O. Dezentjé, Hans Gelderblom, Ron H. N. Van Schaik, Judith M. Vletter-Bogaartz, Tahar Van der Straaten, Judith A. M. Wessels, Elma Meershoek-Klein Kranenbarg, Els M. Berns, Caroline Seynaeve, Hein Putter, Cornelis J. H. Van de Velde, Johan W. R. Nortier, Henk-Jan Guchelaar
Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression
Hisani N. Horne, Mark E. Sherman, Montserrat Garcia-Closas, Paul D. Pharoah, Fiona M. Blows, Xiaohong R. Yang, Stephen M. Hewitt, Catherine M. Conway, Jolanta Lissowska, Louise A. Brinton, Ludmila Prokunina-Olsson, Sarah-Jane Dawson, Carlos Caldas, Douglas F. Easton, Stephen J. Chanock, Jonine D. Figueroa
Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer
Yanhong Liu, Renke Zhou, Lars O. Baumbusch, Spyros Tsavachidis, Abenaa M. Brewster, Kim-Anh Do, Aysegul Sahin, Gabriel N. Hortobagyi, Joseph H. Taube, Sendurai A. Mani, Jørgen Aarøe, Fredrik Wärnberg, Anne-Lise Børresen-Dale, Gordon B. Mills, Patricia A. Thompson, Melissa L. Bondy
Preoperative breast MRI and surgical outcomes in elderly women with invasive ductal and lobular carcinoma: a population-based study
Alice K. Fortune-Greeley, Stephanie B. Wheeler, Anne-Marie Meyer, Katherine E. Reeder-Hayes, Andrea K. Biddle, Hyman B. Muss, William R. Carpenter